Healthcare Global Enterprise to focus on footfalls, asset use to increase profit

The Bengaluru-based cancer care provider has been in scale-up mode setting up new cancer centres till FY19, but just as it was trying to ramp up operations at new centres, it was hit by covid related headwinds. With the pandemic wearing off, HCG is seeing strong momentum in growth and profitability. The company said it was targeting 18-20% return on capital employed in the next 2-3 years from the current 14%. HCG saw 23% YoY growth in H1FY23 to ₹828 crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vGimNoA
via IFTTT